Resmed Inc. buy CLSA
Start price
02.09.25
/
50%
€232.70
Target price
02.09.26
-
Performance (%)
-24.58%
Price
08.05.26
€175.50
Summary
This prediction is currently active. The price of Resmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -24.58%. This prediction currently runs until 02.09.26. The prediction end date can be changed by CLSA at any time. CLSA has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -3.237% | -3.237% |
| iShares Core DAX® | 0,42 % | 5,71 % |
| iShares Nasdaq 100 | 4,10 % | 16,64 % |
| iShares Nikkei 225® | 4,47 % | 18,34 % |
| iShares S&P 500 | 1,79 % | 9,64 % |
Comments by CLSA for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) was upgraded by analysts at CLSA from a "hold" rating to an "outperform" rating.
Ratings data for RMD provided by MarketBeat